3/17
05:14 pm
zntl
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 [Yahoo! Finance]
3/17
04:30 pm
zntl
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
Medium
Report
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
3/17
10:09 am
zntl
Zentalis Pharmaceuticals (ZNTL) is now covered by Wells Fargo & Company. They set an "equal weight" rating and a $5.00 price target on the stock.
Low
Report
Zentalis Pharmaceuticals (ZNTL) is now covered by Wells Fargo & Company. They set an "equal weight" rating and a $5.00 price target on the stock.
2/18
08:00 am
zntl
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
2/3
04:05 pm
zntl
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference
Medium
Report
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference
1/11
06:05 pm
zntl
A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Progress And Insider Buying [Yahoo! Finance]
High
Report
A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Progress And Insider Buying [Yahoo! Finance]
1/6
08:00 am
zntl
Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026
High
Report
Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026